ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+7.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4M
AUM Growth
-$93.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$1.39M
2
+$947K
3
+$837K
4
EHC icon
Encompass Health
EHC
+$834K
5
PFE icon
Pfizer
PFE
+$477K

Top Sells

1
+$15.5M
2
+$6.93M
3
+$6.53M
4
ELV icon
Elevance Health
ELV
+$5.03M
5
TMO icon
Thermo Fisher Scientific
TMO
+$4.87M

Sector Composition

1 Healthcare 98.36%
2 Real Estate 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
26
DexCom
DXCM
$28.3B
– –
-20,694
ETNB
27
DELISTED
89bio
ETNB
– –
-82,153
RNAC icon
28
Cartesian Therapeutics
RNAC
$197M
– –
-15,110
ABT icon
29
Abbott
ABT
$198B
– –
-18,040
ACLX icon
30
Arcellx
ACLX
$6.59B
– –
-14,158
ADAP
31
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-311,944
AHCO icon
32
AdaptHealth
AHCO
$1.31B
– –
-89,937
ARGX icon
33
argenx
ARGX
$46.8B
– –
-9,108
AXSM icon
34
Axsome Therapeutics
AXSM
$8.38B
– –
-11,254
AZN icon
35
AstraZeneca
AZN
$316B
– –
-96,444
AZTA icon
36
Azenta
AZTA
$1.24B
– –
-19,422
BLUE
37
DELISTED
bluebird bio
BLUE
– –
-12,589
BRKR icon
38
Bruker
BRKR
$6.05B
– –
-111,276
CNMD icon
39
CONMED
CNMD
$1.41B
– –
-41,984
GDRX icon
40
GoodRx Holdings
GDRX
$737M
– –
-87,290
INSM icon
41
Insmed
INSM
$31.8B
– –
-79,471
IQV icon
42
IQVIA
IQV
$30.3B
– –
-3,946
MRK icon
43
Merck
MRK
$300B
– –
-44,384
OLMA icon
44
Olema Pharmaceuticals
OLMA
$1.93B
– –
-58,573
SYK icon
45
Stryker
SYK
$148B
– –
-7,547
TARS icon
46
Tarsus Pharmaceuticals
TARS
$3.3B
– –
-47,649
TLT icon
47
iShares 20+ Year Treasury Bond ETF
TLT
$44.9B
– –
-3,400
TXG icon
48
10x Genomics
TXG
$2.96B
– –
-71,044
VTYX icon
49
Ventyx Biosciences
VTYX
$1B
– –
-18,458
NVST icon
50
Envista
NVST
$4.79B
– –
-10,787
1
2
3